evidence table

Coconut Oil Blood Pressure Randomized Trial Evidence Table

Structured evidence table for Coconut Oil Blood Pressure Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Coconut Oil Blood Pressure Randomized TrialThis distinction helps explain why higher POA in cholesterol esters, phospholipids, or adipose tissue is often associated with hypertriglyceridemia, abdominal adiposity, insulin resistance, non-alcoholic fatty liver disease, and vascular risk, whereas some studies of free POA or specific phospholipid pools report associations with better insulin sensitivity or lower diabetes risk (–).3Destaillats Frédéric (2026)Palmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
Coconut Oil Blood Pressure Randomized TrialThe sections below organize the evidence by metabolic domain and emphasize the need to distinguish endogenous POA as a marker of lipogenesis from exogenous POA delivered in foods or supplements.3Destaillats Frédéric (2026)Palmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
Coconut Oil Blood Pressure Randomized Triallowest quartile of plasma POA had ~2-fold higher triglyceridemia, and POA remained independently associated with both hypertriglyceridemia and abdominal adiposity in multivariable models ().3Destaillats Frédéric (2026)Palmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
Coconut Oil Blood Pressure Randomized Trialcis 1 2 3 10 Palmitoleic acid (POA; 16:1 n-7 or-9 16:1) is a monounsaturated fatty acid produced primarily through stearoyl-CoA desaturase-1 (SCD1)-mediated desaturation of palmitic acid.3Destaillats Frédéric (2026)Palmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
Coconut Oil Blood Pressure Randomized TrialVirgin coconut oil: A comprehensive review of its health impacts and functional food applications3Khan I (2026)Virgin coconut oil: A comprehensive review of its health impacts and functional food applications
topicCoconut Oil Blood Pressure Randomized Trial
claimThis distinction helps explain why higher POA in cholesterol esters, phospholipids, or adipose tissue is often associated with hypertriglyceridemia, abdominal adiposity, insulin resistance, non-alcoholic fatty liver disease, and vascular risk, whereas some studies of free POA or specific phospholipid pools report associations with better insulin sensitivity or lower diabetes risk (–).
evidence level3
citationDestaillats Frédéric (2026)
sourcePalmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
topicCoconut Oil Blood Pressure Randomized Trial
claimThe sections below organize the evidence by metabolic domain and emphasize the need to distinguish endogenous POA as a marker of lipogenesis from exogenous POA delivered in foods or supplements.
evidence level3
citationDestaillats Frédéric (2026)
sourcePalmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
topicCoconut Oil Blood Pressure Randomized Trial
claimlowest quartile of plasma POA had ~2-fold higher triglyceridemia, and POA remained independently associated with both hypertriglyceridemia and abdominal adiposity in multivariable models ().
evidence level3
citationDestaillats Frédéric (2026)
sourcePalmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
topicCoconut Oil Blood Pressure Randomized Trial
claimcis 1 2 3 10 Palmitoleic acid (POA; 16:1 n-7 or-9 16:1) is a monounsaturated fatty acid produced primarily through stearoyl-CoA desaturase-1 (SCD1)-mediated desaturation of palmitic acid.
evidence level3
citationDestaillats Frédéric (2026)
sourcePalmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
topicCoconut Oil Blood Pressure Randomized Trial
claimVirgin coconut oil: A comprehensive review of its health impacts and functional food applications
evidence level3
citationKhan I (2026)
sourceVirgin coconut oil: A comprehensive review of its health impacts and functional food applications

Learn next

Related evidence and supplement guides

GuideCoconut Oil Blood Pressure Randomized Trial: What the Evidence SaysCoconut Oil Blood Pressure Randomized Trial has 2 source documents in the current Migaku evidenc...GuideBlack Seed Oil Blood Pressure Randomized Trial: What the Evidence SaysBlack Seed Oil Blood Pressure Randomized Trial has 1 source documents in the current Migaku evid...GuideCocoa Flavanol Blood Pressure Randomized Trial: What the Evidence SaysCocoa Flavanol Blood Pressure Randomized Trial has 2 source documents in the current Migaku evid...GuideCoconut Oil Cognition Randomized Trial: What the Evidence SaysCoconut Oil Cognition Randomized Trial has 2 source documents in the current Migaku evidence dat...CompareFish Oil Omega-3 vs Algae Omega-3Both animal and plant sources of omega-3 support heart and brain health, but differ in sustainab...AnswerDoes Coconut Oil Blood Pressure Randomized Trial work?Coconut Oil Blood Pressure Randomized Trial has evidence relevant to strength of evidence and wh...AnswerIs Coconut Oil Blood Pressure Randomized Trial safe?Coconut Oil Blood Pressure Randomized Trial has evidence relevant to safety, limits, and clinici...AnswerWhat does the evidence say about Coconut Oil Blood Pressure Randomized Trial?Coconut Oil Blood Pressure Randomized Trial has evidence relevant to benefits, uncertainty, and...

Source documents

  1. Palmitoleic (16:1 n-7) acid and metabolic health: integrating observational, clinical, and mechanistic evidence
  2. Virgin coconut oil: A comprehensive review of its health impacts and functional food applications